Clinical Trials | February 19, 2026
GSK announces breakthrough data showing RSV vaccine cuts hospitalizations in elderly
The data highlights its RSV vaccine cuts hospitalizations in older adults
The data highlights its RSV vaccine cuts hospitalizations in older adults
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
These results were consistent across all clinically relevant patient subgroups regardless of key patient characteristics like age or sex, the cause of stroke or the severity of the stroke
UK Prime Minister Keir Starmer praised the initiative, saying: “Unlocking opportunities for British businesses across the globe and delivering for working people back home is always the driving force behind my international engagements."
The trials, which enrolled over 1,000 patients across 398 sites in 17 countries, showed that the drug was safe and well-tolerated—but ultimately failed to deliver the hoped-for clinical results
The EU approval of DAWNZERA is an important milestone that reflects our ongoing commitment to bring this innovative medicine to people in need across the globe
This license is a key regulatory milestone in advancing Hester's prevention-led poultry healthcare portfolio
The research shows 93% of global companies now cover weight-management drugs in their health insurance plans
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
Under the deal, ViiV Healthcare will issue new shares to Shionogi for $2.125 billion and cancel Pfizer’s holding
Subscribe To Our Newsletter & Stay Updated
